Stocks and Investing Stocks and Investing
by Source: (remove) : Kevin Caliendo
RSSJSONXMLCSV
Thu, August 15, 2024
Thu, July 18, 2024
Wed, July 3, 2024
Mon, June 24, 2024
Thu, May 23, 2024
Mon, April 15, 2024
Wed, April 3, 2024
Wed, February 28, 2024
Mon, February 5, 2024
Thu, February 1, 2024
Tue, January 30, 2024
Mon, January 29, 2024
Thu, December 21, 2023
Fri, October 27, 2023
Mon, October 16, 2023
Wed, July 19, 2023
Thu, July 13, 2023
Mon, June 12, 2023
Wed, March 29, 2023
Tue, January 31, 2023
Wed, January 18, 2023
Wed, October 19, 2022
Tue, October 11, 2022
Fri, October 7, 2022
Mon, August 29, 2022
Mon, August 8, 2022
Fri, July 29, 2022
Thu, July 21, 2022
Mon, July 18, 2022

Kevin Caliendo Maintained (CAH) at Strong Buy with Increased Target to $125 on, Aug 15th, 2024


Published on 2024-10-28 13:40:05 - WOPRAI, Kevin Caliendo
  Print publication without navigation
Kevin Caliendo of UBS, Maintained "Cardinal Health, Inc." (CAH) at Strong Buy with Increased Target from $120 to $125 on, Aug 15th, 2024.

Kevin has made no other calls on CAH in the last 4 months.



There are 3 other peers that have a rating on CAH. Out of the 3 peers that are also analyzing CAH, 2 agree with Kevin's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Daniel Grosslight of "Citigroup" Maintained at Hold with Decreased Target to $107 on, Friday, July 19th, 2024
  • George Hill of "Deutsche Bank" Maintained at Hold with Decreased Target to $110 on, Monday, May 6th, 2024


This is the rating of the analyst that currently disagrees with Kevin


  • David Toung of "Argus Research" Maintained at Strong Buy with Decreased Target to $115 on, Wednesday, May 15th, 2024
Contributing Sources